174 related articles for article (PubMed ID: 37019641)
21. Survival impact of lung transplantation for COPD.
Lahzami S; Bridevaux PO; Soccal PM; Wellinger J; Robert JH; Ris HB; Aubert JD
Eur Respir J; 2010 Jul; 36(1):74-80. PubMed ID: 19996194
[TBL] [Abstract][Full Text] [Related]
22. Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD.
Tödt K; Skargren E; Kentson M; Theander K; Jakobsson P; Unosson M
Int J Chron Obstruct Pulmon Dis; 2014; 9():17-25. PubMed ID: 24368883
[TBL] [Abstract][Full Text] [Related]
23. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
[TBL] [Abstract][Full Text] [Related]
24. Palliative Care for Patients Dying in the Intensive Care Unit with Chronic Lung Disease Compared with Metastatic Cancer.
Brown CE; Engelberg RA; Nielsen EL; Curtis JR
Ann Am Thorac Soc; 2016 May; 13(5):684-9. PubMed ID: 26784137
[TBL] [Abstract][Full Text] [Related]
25. Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.
Cebrià I Iranzo MÀ; Vos R; Verleden GM; Gosselink R; Langer D
Arch Bronconeumol (Engl Ed); 2019 May; 55(5):239-245. PubMed ID: 30595421
[TBL] [Abstract][Full Text] [Related]
26. Lung transplantation for interstitial lung disease.
Kapnadak SG; Raghu G
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348979
[TBL] [Abstract][Full Text] [Related]
27. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.
Khadawardi H; Mura M
Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639
[TBL] [Abstract][Full Text] [Related]
28. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of patients awaiting lung transplantation after the implementation of donation after brain death at a single Chinese center.
Yang Y; Xu X; Liu M; Zhao Y; Yu Y; Liu X; Chen C; Jiang G; He W
Front Med; 2022 Oct; 16(5):760-765. PubMed ID: 35776403
[TBL] [Abstract][Full Text] [Related]
30. Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients.
Chai GT; Neo HY; Abisheganaden J; Hum AYM
Am J Hosp Palliat Care; 2022 Dec; 39(12):1443-1451. PubMed ID: 35389277
[No Abstract] [Full Text] [Related]
31. Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease.
Gersten RA; Seth B; Arellano L; Shore J; O'Hare L; Patel N; Safdar Z; Krishna R; Mageto Y; Cochran D; Lindell K; Danoff SK;
Chest; 2022 Aug; 162(2):375-384. PubMed ID: 35305969
[TBL] [Abstract][Full Text] [Related]
32. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
[TBL] [Abstract][Full Text] [Related]
33. Determinants of physical activity in daily life in candidates for lung transplantation.
Langer D; Cebrià i Iranzo MA; Burtin C; Verleden SE; Vanaudenaerde BM; Troosters T; Decramer M; Verleden GM; Gosselink R
Respir Med; 2012 May; 106(5):747-54. PubMed ID: 22305265
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary vascular pressure respiratory swings in COPD and ILD candidates for lung transplantation: Large but different.
Grignola JC; Calabuig A; Trujillo P; Bravo C; Azpiroz F; Messeguer ML; Domingo E
Pulm Circ; 2024 Jan; 14(1):e12348. PubMed ID: 38449519
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease.
Jensen D; Schaeffer MR; Guenette JA
Curr Opin Support Palliat Care; 2018 Sep; 12(3):237-245. PubMed ID: 30074922
[TBL] [Abstract][Full Text] [Related]
36. Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system.
De Oliveira NC; Osaki S; Maloney J; Cornwell RD; Meyer KC
Eur J Cardiothorac Surg; 2012 Mar; 41(3):680-5. PubMed ID: 22219404
[TBL] [Abstract][Full Text] [Related]
37. Impact of dyspnea on advanced cancer patients referred to a palliative radiotherapy clinic.
Rowbottom L; Chan S; Zhang L; McDonald R; Barnes E; Tsao M; Zaki P; Chow E
Support Care Cancer; 2017 Sep; 25(9):2691-2696. PubMed ID: 28341970
[TBL] [Abstract][Full Text] [Related]
38. Assessing Symptom Burden and Depression in Subjects With Chronic Respiratory Insufficiency.
Rantala HA; Leivo-Korpela S; Lehtimäki L; Lehto JT
J Palliat Care; 2022 Apr; 37(2):134-141. PubMed ID: 34841962
[No Abstract] [Full Text] [Related]
39. Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy - The population-based DISCOVERY study.
Palm A; Ekström M
Respir Med; 2021; 189():106659. PubMed ID: 34700206
[TBL] [Abstract][Full Text] [Related]
40. Performance of the COPD Assessment Test in patients with connective tissue disease-associated interstitial lung disease.
Suzuki A; Kondoh Y; Swigris JJ; Matsuda T; Kimura T; Kataoka K; Ando M; Hashimoto N; Sakamoto K; Hasegawa Y
Respir Med; 2019 Apr; 150():15-20. PubMed ID: 30961943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
